(Q58976910)

English

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. EORTC Leukemia Cooperative Group

scientific article published on 01 April 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1581405%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. EORTC Leukemia Cooperative Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1581405%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Colony stimulating factor 2

1 reference

based on heuristic

inferred from title

Alice K. Jacobs

object named as

A. Jacobs

11

0 references

author name string

R. Willemze

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581405

11 October 2022

N. van der Lely

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581405

11 October 2022

H. Zwierzina

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581405

11 October 2022

S. Suciu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581405

11 October 2022

G. Solbu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581405

11 October 2022

H. Gerhartz

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581405

11 October 2022

B. Labar

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581405

11 October 2022

G. Visani

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581405

11 October 2022

M. E. Peetermans

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581405

11 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1581405

11 October 2022

publication date

1 April 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1581405%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1581405%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

64

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1581405%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1581405%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

173-180

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1581405%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1007%2FBF01696219

21 January 2018

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial

1 reference

https://api.crossref.org/works/10.1007%2FBF01696219

21 January 2018

Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelodysplastic syndromes: a scoring system with prognostic significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1581405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01696219

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1581405%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1581405%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58976910&oldid=2151614128"